 Home > Active Ingredient News > Study of Nervous System > JAMA Neurol: The relationship between the use of enzyme-induced antiepileptic drugs and long-term cardiovascular disease

JAMA Neurol: The relationship between the use of enzyme-induced antiepileptic drugs and long-term cardiovascular disease

 Last Update: 2021-11-13
 Source: Internet
 Author: User

Tags

all compounds

potential hazards health un1825

Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

Epilepsy Patients suffering from heart blood vessels at high risk of the disease
.

Compared with the general population, ischemic heart disease, transient ischemic attack, cerebral ischemic stroke and hemorrhagic stroke, which may be part of the epilepsy itself, sedentary behavior, high smoking rates, lower socioeconomic status , Obesity is related to self-reported health conditions

Epilepsy Patients suffering from heart blood vessels at high risk of the disease

Anti-epileptic drugs (ASM), especially enzyme-induced ASM (EIASM) may also work

Recently, some researchers have quantified and modeled the postulated risk of cardiovascular disease after the use of EASM

This cohort study covered the period from January 1990 to March 2019 (median [IQR] follow-up, 9 years [4-15 years])
.

This study links the primary care of the National Health Service in the UK with the hospital's electronic health records

This cohort study covered the period from January 1990 to March 2019 (median [IQR] follow-up, 9 years [4-15 years])

After the diagnosis of adult onset (age ≥ 18 years) epilepsy or repeated exposure in the weighted cumulative exposure model, consecutively received 4 EASMs (carbamazepine, eslicarbazepine, oxcarbazepine, phenobarbital, phenytoin, Primidone, rufenamide or topiramate)

Three cohorts were isolated.

Among 10,916,166 adults, 50,888 (0.

Patients receiving EASM treatment have a higher risk of cardiovascular disease

Literature source: https://jamanetwork-com.
washington.
80599.
net/journals/jamaneurology/fullarticle/2784443?resultClick=1 https://jamanetwork-com.
washington.
80599.
net/journals/jamaneurology/fullarticle/2784443? resultClick=1 leave a message here

This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

Related Products

Sodium bromide airuike

CAS No.: 7647-15-6

Industrial Grade

$10/KG EXW

Brivaracetam357336-20-0

CAS No.: 357336-20-0

API Grade

$100/KG EXW

Quetiapine fumarate CAS 111974-72-2

CAS No.: 111974-72-2

Pharmaceutical Grade

$100/KG EXW

Hot Tags

united states jobs(223)

jobs united states(236)

1 year treasury(277)

1 year subscription(296)

single use technology(195)

announcements today(81)

ups united states(221)

united states logo(227)

80 20 company(94)

healthy food name(42)

Hot Articles

The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.